News Medical: Study identifies key priorities for research on reducing psychiatric medication
Study hopes to inform the research agenda and help future research to focus on the questions that are most important to key stakeholders. The global consumption of psychiatric medication is increasing ...
News Medical: Study reveals ADHD medication reduces psychiatric hospitalizations and work disability
The use of psychiatric medications to treat mental health and behavioral disorders in children and young adults has risen over the past 20 years – including the prescribing of more than one medication ...
Mad in America: Psychiatric Coercion Results in Overmedication and Lower Perceived Quality of Care
This week, Mad in America examines three studies around coercion in psychiatric treatment. The first study finds that involuntarily treated patients are Evidence from three studies highlights ...
Nasdaq: Myriad Genetics Study Finds GeneSight Test Reduces Psychiatric Hospitalizations in Major Depressive Disorder Patients
Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
Myriad Genetics Study Finds GeneSight Test Reduces Psychiatric Hospitalizations in Major Depressive Disorder Patients
Medscape: Early Psychiatric Medication Resumption in the Emergency Department Shows Mixed Impact on Length of Stay
In a multicenter emergency department (ED) cohort of patients on chronic psychiatric medications, restarting outpatient medications within 24 hours was not associated with the overall length of stay ...
Early Psychiatric Medication Resumption in the Emergency Department Shows Mixed Impact on Length of Stay
New research shows that people who take certain psychiatric medications may be more likely to develop amyotrophic lateral sclerosis (ALS), which is the most common form of motor neurone disease (MND).